GlassScriptPhysician profile
Bailey Minehart
NPI 1073076089
$1,679.34
in general payments reported to CMS, 2019-2025
10 companies · $936 in 2025
The $936 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $418 · 2024: $204 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520 · Travel and Lodging: $38.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.52 |
| Travel and Lodging | $38.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $473.10 | 2022-2025 | Audion Et Dilation System, Scopis Ent, Xpress Ent Dilation System |
| Medtronic, INC. | $419.97 | 2022-2025 | Propel, Stealthstation S8 Platform, Pteye Parathyroid Detection System |
| Inspire Medical Systems, INC. | $273.83 | 2025 | Inspire |
| Olympus America INC. | $145.54 | 2023 | Rhino-Laryngo Videoscope |
| Aerin Medical INC. | $143.95 | 2024-2025 | |
| Galderma Laboratories, L.P. | $109.84 | 2024 | |
| Baxter Healthcare | $54.33 | 2025 | Artiss |
| Genzyme Corporation | $23.44 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $19.64 | 2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $15.70 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Minehart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.